Leslie Madden is the Senior Director, Head of Government Affairs & Policy at Moderna Canada, where she leads engagement to advance policies that support innovation in mRNA vaccines, therapeutics, pandemic preparedness, and the growth of Canada’s life sciences ecosystem.
Leslie brings more than 20 years of pharmaceutical industry experience in Canada and the US. Prior to her current role, she joined Moderna as one of its first Canadian employees in early 2021 as the Head of Regulatory Sciences & QA. In that position, she led the company’s regulatory strategy and execution during the COVID-19 pandemic, securing Canadian approvals for Moderna’s COVID-19 vaccine and respiratory portfolio. She also contributed to building the company’s regulatory frameworks to support clinical development and rare disease programs in Canada. She has previously held positions in both commercial and R&D functions at Elvium Life Sciences, Biogen, Galderma and GSK.
Leslie brings more than 20 years of experience in the pharmaceutical sector in both Canada and the US. She holds a BSc from York University, an MBA from Rotman School of Management (UofT), and a Global Professional LLM from the Jackman Faculty of Law (UofT).
